NDC-1308 potently enhances remyelination

[MSUK]

NDC-1308 potently enhances remyelination in experimental models of multiple sclerosis

Scientists from ENDECE Neural presented preclinical data today showing that the company’s lead compound, NDC-1308, addresses one of the root causes of multiple sclerosis (MS) by significantly inducing remyelination in nerves that have been damaged by MS. In an oral presentation at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Copenhagen, Denmark, the ENDECE Neural researchers also reported a dramatic upregulation of genes in signaling pathways involved in myelin sheath production......... Read More - http://www.ms-uk.org/myelin

[HarryZ]

I must say reading the first part of the post really caught my attention....until I read further that the results were obtained from experiments on that poor MS mouse!!

I really hope that these findings can be translated into similar results with human MS but we all know the track record between EAE and human MS treatments.

Harry